Cells are the quanta unit of biology ? the keys to understanding and defeating disease. CytoReason knows cells. With one of the world?s largest libraries of human molecular data, and a model to make that data accessible and useful, CytoReason builds unique computational cell-level models of the human body that accurately and rapidly transform data into biological insights that advance pharmaceutical R&D, and help manage disease. This is why the world?s leading pharmaceutical companies work with us ? helping them to discover, develop and deliver better therapies for the patients that need them.
Total Funding: $130M
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 101 to 250
Founded: 2016
Jul 2024
- Funding: CytoReason raised $80M Funded round. Total funding reached to $130M
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at CytoReason
CytoReason - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
CytoReason - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started